APIXABAN-FORMULIERUNGEN

Patent europeic · EP3017811 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3017811
Numer da la dumonda
EP15190823
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
24-02-2011
Publitgà
11-05-2016
Concedì
05-12-2018
Stritgà
24-04-2024
Motiv
Revocà en la procedura d’opposiziun
Classas IPC
A61K 9/20 (2006.01)
A61K 31/4545 (2006.01)
A61P 7/02 (2006.01)
Prioritad
US 308056 P 25.02.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 26-04-2024

    Publicaziun

    Published in Swissreg on 26.04.2024

  2. 24-04-2024

    Midada

    Published in Swissreg on 24.04.2024

  3. 27-03-2024

    Midada

    Published in Swissreg on 27.03.2024

  4. 01-03-2024

    Midada

    Published in Swissreg on 01.03.2024

  5. 27-12-2023

    Midada

    Published in Swissreg on 27.12.2023

  6. 06-03-2023

    Midada

    Published in Swissreg on 06.03.2023

  7. 09-01-2023

    Adressa midada

    Representative
    ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich → Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg

    Published in Swissreg on 09.01.2023

  8. 16-02-2022

    Midada

    Published in Swissreg on 16.02.2022

7 endataziuns pli veglias
  1. 27-10-2021

    Midada

    Published in Swissreg on 27.10.2021

  2. 23-09-2021

    Midada

    Published in Swissreg on 23.09.2021

  3. 23-09-2021

    Midada

    Published in Swissreg on 23.09.2021

  4. 04-06-2020

    Adressa midada

    Representative
    Servopatent GmbH, Resirain 1, 8125 Zollikerberg → ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich

    Published in Swissreg on 04.06.2020

  5. 14-03-2019

    Represchentant inscrit

    Representative
    Servopatent GmbH, Resirain 1, 8125 Zollikerberg

    Published in Swissreg on 14.03.2019

  6. 06-03-2019

    Owner

    Owner
    Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA, Bristol-Myers Squibb Holdings Ireland, Hinterbergstrasse 16, 6312 Steinhausen → Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA, Bristol-Myers Squibb Holdings Ireland, Unlimited Company, Hinterbergstrasse 16, 6312 Steinhausen

    Published in Swissreg on 06.03.2019

  7. 05-12-2018

    Concedì

    Published in Swissreg on 05.12.2018

Partidas

Possessur

Pfizer Inc.

235 East 42nd Street, New York, NY 10017, US

Bristol-Myers Squibb Holdings Ireland Unlimited Company

Hinterbergstrasse 16, 6312 Steinhausen

Represchentant

Servopatent GmbH

Bühlstrasse 1, 8125 Zollikerberg

Inventur

FROST, Charles

Princton, NJ New Jersey 08543, US

PATEL, Jatin

Princton, NJ New Jersey 08543, US

JIA, Jingpin

Princton, NJ New Jersey 08543, US

VEMA-VARAPU, Chandra

Princton, NJ New Jersey 08543, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.